Physician profile
Ankur Ashok Rughani
NPI 1346628856
$20,380.42
in general payments reported to CMS, 2019-2025
35 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2022: $612 · 2023: $1,780 · 2024: $3,604 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $5,167 · Consulting Fee: $1,980 · Education: $80.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,416.25 |
| Food and Beverage | $5,166.91 |
| Consulting Fee | $1,980.00 |
| Education | $80.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12,330.41 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $2,287.50 | 2019-2025 | Strensiq |
| Kyowa Kirin, INC. | $1,368.54 | 2024-2025 | Crysvita |
| Ascendis Pharma Endocrinology INC | $588.02 | 2022-2025 | Skytrofa |
| Tandem Diabetes Care, INC. | $517.35 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Tolmar, INC. | $420.57 | 2023-2025 | Fensolvi |
| Abbvie INC. | $341.18 | 2023-2025 | Lupron Depot |
| Beta Bionics, INC. | $319.50 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Xeris Pharmaceuticals, INC. | $228.95 | 2022-2025 | Gvoke Hypopen |
| Abbott Laboratories | $216.93 | 2023-2025 | Freestyle Libre 3 |
| Biomarin Pharmaceutical INC. | $169.91 | 2022-2025 | Voxzogo 1.2mg |
| Ucb, INC. | $136.09 | 2022-2024 | Fintepla, Nayzilam |
| Eisai INC. | $131.82 | 2022 | |
| Dexcom, INC. | $131.61 | 2024-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $124.96 | 2023-2025 | Sogroya |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eton Pharmaceuticals, INC. | $120.89 | 2023-2025 | Alkindi, Increlex, Khindivi |
| Insulet Corporation | $112.70 | 2022-2025 | Omnipod |
| Pfizer INC. | $99.26 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $82.43 | 2025 | |
| Rhythm Pharmaceuticals, INC. | $78.70 | 2025 | Imcivree |
| Takeda Pharmaceuticals U.S.A., INC. | $76.28 | 2024-2025 | Eohilia |
| Regeneron Healthcare Solutions, INC. | $74.18 | 2025 | Dupixent, Evkeeza |
| Tolmar Pharmaceuticals, INC. | $65.92 | 2022 | |
| Mannkind Corporation | $61.53 | 2025 | |
| Lilly USA, LLC | $53.48 | 2022-2023 | Baqsimi |
| Neurelis, INC. | $36.89 | 2023 | Valtoco |
| Aquestive Therapeutics, INC. | $31.90 | 2022 | |
| Sequel Med Tech, LLC | $25.34 | 2025 | Twiist |
| Soleno Therapeutics, INC. | $24.27 | 2025 | Vykat Xr |
| Endo USA, INC. | $23.53 | 2024 | Supprelin |
| Ptc Therapeutics, INC. | $23.50 | 2022 | |
| Medtronic, INC. | $22.51 | 2025 | Minimed 780g |
| Genzyme Corporation | $20.29 | 2024 | |
| Ibsa Pharma INC. | $19.42 | 2025 | Flector, Licart, Tirosint |
| Nestle Healthcare Nutrition INC. | $14.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Rughani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.